28.02.2020 • NewsElaine BurridgeUOPPKN Orlen

UOP Provides Cumene/Phenol Units to PKN Orlen

UOP Provides Cumene/Phenol Units to PKN Orlen (c) PKN Orlen
UOP Provides Cumene/Phenol Units to PKN Orlen (c) PKN Orlen

Honeywell is licensing its UOP Q-Max and phenol 3G technologies to Poland’s PKN Orlen for a of 200,000 t/y phenol plant at Plock. Financial terms of the contract were not disclosed , and a start-up date was not given.

UOP is providing a technology license along with basic engineering design services as well as key equipment, catalysts and adsorbents, and technical services. As part of the project, UOP will provide cumene and phenol units with alpha methyl styrene hydrogenation.

“These technologies make it possible for PKN Orlen to extend its benzene production into phenol and acetone derivatives,” said Bryan Glover, vice president and general manager of Honeywell UOP’s Petrochemicals & Refining Technologies business. “By doing so, PKN Orlen would be in a position to meet the growing demand for phenol and other petrochemicals in Poland and even become a net exporter of those products.”

UOP’s Q-Max process converts benzene and propylene into high-quality cumene while the 3G phenol unit converts cumene into phenol with high yields and product quality. Phenol is used to make plastics and related products, including bisphenol-A, the feedstock for polycarbonate, and phenolic resins, which are used to make durable laminated boards and industrial adhesives.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.